HYMAN CHARLES D - MEDGENICS INC ownership

Quarter-by-quarter ownership
HYMAN CHARLES D ownership history of MEDGENICS INC
ValueSharesWeighting
Q3 2016$84,0000.0%15,1430.0%0.01%
-7.7%
Q2 2016$84,000
+25.4%
15,1430.0%0.01%
+18.2%
Q1 2016$67,000
-26.4%
15,1430.0%0.01%
-26.7%
Q4 2015$91,000
-10.8%
15,143
+16.5%
0.02%
-16.7%
Q3 2015$102,000
+27.5%
13,0000.0%0.02%
+38.5%
Q2 2015$80,000
-23.8%
13,0000.0%0.01%
-23.5%
Q1 2015$105,000
+59.1%
13,0000.0%0.02%
+54.5%
Q4 2014$66,000
-12.0%
13,000
-10.3%
0.01%
-15.4%
Q3 2014$75,000
-33.6%
14,5000.0%0.01%
-31.6%
Q2 2014$113,000
+11.9%
14,5000.0%0.02%
+5.6%
Q1 2014$101,000
+16.1%
14,5000.0%0.02%
+12.5%
Q4 2013$87,000
-23.0%
14,5000.0%0.02%
-27.3%
Q3 2013$113,000
+105.5%
14,5000.0%0.02%
+100.0%
Q2 2013$55,00014,5000.01%
Other shareholders
MEDGENICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,058,400$8,277,0004.07%
Belmont Global Advisors, Inc. 155,000$1,212,0002.06%
Broadfin Capital, LLC 1,545,306$12,084,0000.67%
CARL DOMINO INC 34,134$267,0000.21%
QVT Financial LP 267,608$2,093,0000.07%
WHITE PINE CAPITAL LLC 20,000$156,0000.07%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 119,000$931,0000.02%
HYMAN CHARLES D 13,000$102,0000.02%
Kavar Capital Partners, LLC 1,500$11,0000.01%
Brick & Kyle, Associates 1,000$8,0000.01%
View complete list of MEDGENICS INC shareholders